Dysarthria in amyotrophic lateral sclerosis: A review
The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Dysarthria is a motor disorder of speech characterized by abnormalities of the articulation and intelligibility of speech. Phonation and the rate of facial movements may also be affected. Understanding the nature and course of dysarthria in amyotrophic lateral sclerosis (ALS) is important because loss of communication prevents patients from participating in many activities, may lead to social isolation, and reduces the quality of life. The goal of management of dysarthria in ALS patients is to optimize communication effectiveness for as long as possible. The information about dysarthria in ALS is dispersed in physiological, pathological, speech therapy, otorhinolaringological and neurological publications. This review summarizes the current state of knowledge on the clinical features, differential diagnosis, pathophysiology, investigations and management of dysarthria in ALS patients. There is a need to compare the different methods used to assess dysarthria and for controlled clinical trials to assess therapeutic strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, brainstem-stroke survivors4,133,134 and individuals with ALS135 can retain varying degrees of control over orofacial movements and vocalization.”
From The speech neuroprosthesis (2024) · cites this paper as [135]
Citations
Cites
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307 · cited 3×
“Norris, scale Norris, 1974 (36) Appel scale Appel, 1987 (35) ALS Severity Scale-Speech Hillel, 1989 (33) Charing Cross scales Guiloff, 1990 (39) Goonetilleke, 1994 (37) Guiloff, 1994 (40) Goonetilleke, 1995 (38) Guiloff, 1995 (41) ALSFRS -R Cedarbaum, 1999 (34) Frenchay Dysarthria scale Enderby, 1980 (58) Otolaryngolo…”
Differential diagnostic patterns of dysarthria
Darley, F. L., Aronson, A. E., & Brown, J. R. (1969) · Journal of Speech and Hearing Research · doi:10.1044/jshr.1202.246 · Cited by 1,323 · cited 4×
“Muscle wasting and weakness with proportional slowness of movements is characteristic of LMN involvement, while marked slowness of movement with variable weakness and no wasting are features of UMN dysarthria (14).”
BackgroundInfluentialClusters of Deviant Speech Dimensions in the Dysarthrias
Darley, F. L., Aronson, A. E., & Brown, J. R. (1969) · Journal of Speech and Hearing Research · doi:10.1044/jshr.1203.462 · Cited by 784 · cited 3×
“Dysarthria is first assessed in clinical practice by listening to speech when taking a history, also called ‘perceptual’ assessment (13,14).”
BackgroundRespiratory Care of the Patient with Duchenne Muscular Dystrophy: ATS Consensus Statement
(2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200307-885st · Cited by 733
A P300-based brain–computer interface for people with amyotrophic lateral sclerosis
Nijboer, F., Sellers, E. W., Mellinger, J., Jordan, M. A., Matuz, T., Furdea, A., Halder, S., Mochty, U., Krusienski, D. J., Vaughan, T. M., et al. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2008.03.034 · Cited by 633
Are amyotrophic lateral sclerosis patients cognitively normal?
Lomen-Hoerth, C., Murphy, J., Langmore, S., Kramer, J. H., Olney, R. K., & Miller, B. (2003) · Neurology · doi:10.1212/01.wnl.0000055861.95202.8d · Cited by 620
Frenchay Dysarthria Assessment
Enderby, P. (1980) · International Journal of Language & Communication Disorders · doi:10.3109/13682828009112541 · Cited by 588 · cited 2×
“Norris, scale Norris, 1974 (36) Appel scale Appel, 1987 (35) ALS Severity Scale-Speech Hillel, 1989 (33) Charing Cross scales Guiloff, 1990 (39) Goonetilleke, 1994 (37) Guiloff, 1994 (40) Goonetilleke, 1995 (38) Guiloff, 1995 (41) ALSFRS -R Cedarbaum, 1999 (34) Frenchay Dysarthria scale Enderby, 1980 (58) Otolaryngolo…”
MethodBrain-computer communication: Unlocking the locked in.
Kübler, A., Kotchoubey, B., Kaiser, J., Wolpaw, J. R., & Birbaumer, N. (2001) · Psychological Bulletin · doi:10.1037//0033-2909.127.3.358 · Cited by 553
Pahwa, R., Factor, S. A., Lyons, K. E., Ondo, W. G., Gronseth, G., Bronte-Stewart, H., Hallett, M., Miyasaki, J., Stevens, J., & Weiner, W. J. (2006) · Neurology · doi:10.1212/01.wnl.0000215250.82576.87 · Cited by 499
Frontal lobe dementia and motor neuron disease.
Neary, D., Snowden, J. S., Mann, D. M., Northen, B., Goulding, P. J., & Macdermott, N. (1990) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.1.23 · Cited by 438
Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS)
Abrahams, S., Leigh, P. N., Harvey, A., Vythelingum, G. N., Grisé, D., & Goldstein, L. H. (2000) · Neuropsychologia · doi:10.1016/s0028-3932(99)00146-3 · Cited by 411
Real-time EEG analysis with subject-specific spatial patterns for a brain-computer interface (BCI)
Guger, C., Ramoser, H., & Pfurtscheller, G. (2000) · IEEE Transactions on Rehabilitation Engineering · doi:10.1109/86.895947 · Cited by 383
Traynor, B. J., Codd, M. B., Corr, B., Forde, C., Frost, E., & Hardiman, O. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.8.1171 · Cited by 380 · cited 1×
“Dysarthria as an initial symptom is eight times more frequent than dysphagia in ALS (12).”
BackgroundResearch on speech motor control and its disorders
Kent, R. D. (2000) · Journal of Communication Disorders · doi:10.1016/s0021-9924(00)00023-x · Cited by 332 · cited 2×
“Symptoms of dysarthria may not be evident until about 80% of motor neurons are lost (10).”
BackgroundTurner, G. S., Tjaden, K., & Weismer, G. (1995) · Journal of Speech, Language, and Hearing Research · doi:10.1044/jshr.3805.1001 · Cited by 327 · cited 3×
“The vowel space was found to account for 45% of the variance in speech intelligibility (32).”
BackgroundAndersen, P. M., Borasio, G. D., Dengler, R., Hardiman, O., Kollewe, K., Leigh, P. N., Pradat, P. ‐., Silani, V., & Tomik, B. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01351.x · Cited by 289 · cited 4×
“The EFNS-ALS guidelines (76) suggest as good practice points assessment of communication (every three to six months) and the use of appropriate communication support systems.”
BackgroundInfluentialSelf-citationThe administration of guanidine in amyotrophic lateral sclerosis
NORRIS, F. H., CALANCHINI, P. R., FALLAT, R. J., PANCHARI, S., & JEWETT, B. (1974) · Neurology · doi:10.1212/wnl.24.8.721 · Cited by 282
AMYOTROPHIC LATERAL SCLEROSIS: A Clinicoanatomic Study of Fifty-Three Cases
LAWYER, T. (1953) · A.M.A. Archives of Neurology & Psychiatry · doi:10.1001/archneurpsyc.1953.02320260029002 · Cited by 281
The management of motor neurone disease
Leigh, P. N. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.suppl_4.iv32 · Cited by 226
A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience
Appel, V., Stewart, S. S., Smith, G., & Appel, S. H. (1987) · Annals of Neurology · doi:10.1002/ana.410220308 · Cited by 226 · cited 2×
“Norris, scale Norris, 1974 (36) Appel scale Appel, 1987 (35) ALS Severity Scale-Speech Hillel, 1989 (33) Charing Cross scales Guiloff, 1990 (39) Goonetilleke, 1994 (37) Guiloff, 1994 (40) Goonetilleke, 1995 (38) Guiloff, 1995 (41) ALSFRS -R Cedarbaum, 1999 (34) Frenchay Dysarthria scale Enderby, 1980 (58) Otolaryngolo…”
The effects of motor neurone disease on language: Further evidence
Bak, T. H., & Hodges, J. R. (2004) · Brain and Language · doi:10.1016/s0093-934x(03)00357-2 · Cited by 218
Amyotrophic Lateral Sclerosis Severity Scale
Hillel, A. D., Miller, R. M., Yorkston, K., McDonald, E., Norris, F. H., & Konikow, N. (1989) · Neuroepidemiology · doi:10.1159/000110176 · Cited by 211
Rapidly progressive aphasic dementia and motor neuron disease
Caselli, R. J., Windebank, A. J., Petersen, R. C., Komori, T., Parisi, J. E., Okazaki, H., Kokmen, E., Iverson, R., Dinapoli, R. P., Graff‐Radford, N. R., et al. (1993) · Annals of Neurology · doi:10.1002/ana.410330210 · Cited by 211
Yorkston, K. M., & Beukelman, D. R. (1981) · Journal of Speech and Hearing Disorders · doi:10.1044/jshd.4603.296 · Cited by 202 · cited 1×
“Dysarthria usually reduces the intelligibility of speech which can be measured objectively by the Sentence Intelligibility Test (SIT) (59).”
MethodGiess, R. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.1.121 · Cited by 199
Cognitive change in ALS: A prospective study
Abrahams, S., Leigh, P. N., & Goldstein, L. H. (2005) · Neurology · doi:10.1212/01.wnl.0000156519.41681.27 · Cited by 197
Palliative care in amyotrophic lateral sclerosis
Borasio, G. D., Voltz, R., & Miller, R. G. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70049-9 · Cited by 193
Consensus guidelines for the design and implementation of clinical trials in ALS
Miller, R. G., Munsat, T. L., Swash, M., & Brooks, B. R. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00209-9 · Cited by 187 · cited 1×
“A consensus statement from the WFN Research Committee on Motor Neuron Diseases on guidelines for clinical trials in ALS acknowledged that precise measurements of bulbar function needed further development but deemed as validated bulbar functional rating scales (as the ones mentioned above), Frenchay Scale, Hillel Scal…”
BackgroundHypoglossal, trigeminal, and facial motoneuron involvement in amyotrophic lateral sclerosis
DePaul, R., Abbs, J. H., Caligiuri, M. P., Gracco, V. L., & Brooks, B. R. (1988) · Neurology · doi:10.1212/wnl.38.2.281 · Cited by 167
Physiologic Deficits in the Orofacial System Underlying Dysarthria in Amyotrophic Lateral Sclerosis
Langmore, S. E., & Lehman, M. E. (1994) · Journal of Speech, Language, and Hearing Research · doi:10.1044/jshr.3701.28 · Cited by 162
Respiratory aspects of neurological disease
Polkey, M. I., Lyall, R. A., Moxham, J., & Leigh, P. N. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.1.5 · Cited by 140
Palliative care in amyotrophic lateral sclerosis
Borasio, G. D., & Voltz, R. (1997) · Journal of Neurology · doi:10.1007/pl00007719 · Cited by 136
Communication effectiveness of individuals with amyotrophic lateral sclerosis
Ball, L. J., Beukelman, D. R., & Pattee, G. L. (2003) · Journal of Communication Disorders · doi:10.1016/j.jcomdis.2003.09.002 · Cited by 134 · cited 1×
“Important relationships among speech intelligibility and communication effectiveness between speakers and their listeners have been highlighted (78,98).”
BackgroundMultiple Orofacial Indices in Amyotrophic Lateral Sclerosis
DePaul, R., & Brooks, B. R. (1993) · Journal of Speech Language and Hearing Research · doi:10.1044/jshr.3606.1158 · Cited by 133 · cited 2×
“Significant impairment of lingual strength is seen in ALS patients (43,73), greater than the weakness of the jaw and lower lip, even among those without bulbar signs and/or symptoms (71).”
BackgroundCommunication Status and Survival with Ventilatory Support
Bach, J. R. (1993) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-199312000-00002 · Cited by 130 · cited 1×
“Dysarthria significantly reduces the quality of life of ALS patients (6,7).”
BackgroundTreatment Efficacy: Dysarthria
Yorkston, K. M. (1996) · Journal of Speech, Language, and Hearing Research · doi:10.1044/jshr.3905.s46 · Cited by 128 · cited 1×
“Loss of communication prevents ALS patients from participating in a number activities and leads to social isolation (4,5).”
BackgroundDementia and aphasia in motor neuron disease: an underrecognised association?
Rakowicz, W. P., & Hodges, J. R. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.6.881 · Cited by 121
Borasio, G., Shaw, P., Hardiman, O., Ludolph, A., Luis, M. S., & Silani, V (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608201753275517 · Cited by 120
What dysarthrias can tell us about the neural control of speech
Kent, R. D., Kent, J. F., Weismer, G. G., & Duffy, J. R. (2000) · Journal of Phonetics · doi:10.1006/jpho.2000.0122 · Cited by 115 · cited 2×
“The production of speech sounds depends on several highly integrated factors: 1) respiration, 2) phonation, 3) resonation, 4) articulation, and 5) neurological integration (15).”
BackgroundA protocol for identification of early bulbar signs in amyotrophic lateral sclerosis
Ball, L. J., Willis, A., Beukelman, D. R., & Pattee, G. L. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00623-2 · Cited by 115
Quantitative Description of the Dysarthria in Women With Amyotrophic Lateral Sclerosis
Kent, J. F., Kent, R. D., Rosenbek, J. C., Weismer, G., Martin, R., Sufit, R., & Brooks, B. R. (1992) · Journal of Speech, Language, and Hearing Research · doi:10.1044/jshr.3504.723 · Cited by 114
Formant trajectory characteristics of males with amyotrophic lateral sclerosis
Weismer, G. G., Martin, R. E., Kent, R. D., & Kent, J. F. (1992) · The Journal of the Acoustical Society of America · doi:10.1121/1.402635 · Cited by 114 · cited 2×
“reduction of the F2 (second formant)* slope in acoustics and slow force generation in physiology (50).”
BackgroundManagement of oral-pharyngeal dysphagia symptoms in amyotrophic lateral sclerosis
Strand, E. A., Miller, R. M., Yorkston, K. M., & Hıllel, A. D. (1996) · Dysphagia · doi:10.1007/bf00417903 · Cited by 113
Hanayama, K., Ishikawa, Y., & Bach, J. R. (1997) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-199707000-00017 · Cited by 113
Amyotrophic Lateral Sclerosis: Impairment of Neuromuscular Transmission
Denys, E. H. (1979) · Archives of Neurology · doi:10.1001/archneur.1979.00500400056008 · Cited by 109
Impairment of Speech Intelligibility in Men with Amyotrophic Lateral Sclerosis
Kent, R. D., Kent, J. F., Weismer, G. G., Sufit, R. L., Rosenbek, J. C., Martin, R. E., & Brooks, B. R. (1990) · Journal of Speech and Hearing Disorders · doi:10.1044/jshd.5504.721 · Cited by 108 · cited 1×
“Tongue dysfunction in ALS includes reduced range and velocity of movement (36 38,73), reduction in strength (73), smaller vowel space areas (32) and flattening of vowel formant (especially F2 trajectories) (49,50,74).”
BackgroundWeismer, G. G., Laures, J. S., Jeng, J.-Y., Kent, R. D., & Kent, J. F. (2000) · Folia Phoniatrica et Logopaedica · doi:10.1159/000021536 · Cited by 106
Cognition, Language, and Speech in Amyotrophic Lateral Sclerosis: A Review
Strong, M. J., Grace, G. M., Orange, J. B., & Leeper, H. A. (1996) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639608408283 · Cited by 100 · cited 1×
“Abnormal vowel production, which may result in monopitch voice, short phrases, distorted vowels, monoloudness and ‘breathy’ voice quality are also seen (17).”
BackgroundThe acoustic signature for intelligibility test words
Weismer, G., Kent, R. D., Hodge, M., & Martin, R. (1988) · The Journal of the Acoustical Society of America · doi:10.1121/1.396627 · Cited by 100
Otolaryngologic presentations of amyotrophic lateral sclerosis
Chen, A., & Garrett, C. G. (2005) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2004.09.092 · Cited by 99
Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis
Verma, A. K., & Steele, J. (2006) · Muscle & Nerve · doi:10.1002/mus.20545 · Cited by 85
Improving the quality of life for people with ALS: The challenge ahead
Mitsumoto, H., & Bene, M. D. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079464 · Cited by 84 · cited 2×
“Dysarthria significantly reduces the quality of life of ALS patients (6,7).”
BackgroundTraining locked-in patients: a challenge for the use of brain-computer interfaces
Neumann, N., & Kubler, A. (2003) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2003.814431 · Cited by 82
Amyotrophic lateral sclerosis: Abnormalities of the tongue on magnetic resonance imaging
Choon, H., & Patten, B. M. (1989) · Annals of Neurology · doi:10.1002/ana.410250508 · Cited by 80
Speech Deterioration in Amyotrophic Lateral Sclerosis: A Case Study
Kent, R. D., Sufit, R. L., Rosenbek, J. C., Kent, J. F., Weismer, G., Martin, R. E., & Brooks, B. R. (1991) · Journal of Speech, Language, and Hearing Research · doi:10.1044/jshr.3406.1269 · Cited by 80
Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review
Watts, C., Nye, C., & Whurr, R. (2006) · Clinical Rehabilitation · doi:10.1191/0269215506cr931oa · Cited by 78
Laryngeal dysfunction in Amyotrophic Lateral Sclerosis: a review and case report
Watts, C. R., & Vanryckeghem, M. (2001) · BMC Ear Nose and Throat Disorders · doi:10.1186/1472-6815-1-1 · Cited by 74
Speech and language therapy for dysarthria due to non-progressive brain damage
Sellars, C., Hughes, T., & Langhorne, P. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002088.pub2 · Cited by 72 · cited 1×
“There are no published controlled trials in adults to support or refute the effectiveness of pharmacological approaches or of speech and language therapy for dysarthria in ALS or following nonprogressive brain damage (8).”
BackgroundInfluentialAcoustic Analysis of Voice in Amyotrophic Lateral Sclerosis
Ramig, L. O., Scherer, R. C., Klasner, E. R., Titze, I. R., & Horii, Y. (1990) · Journal of Speech and Hearing Disorders · doi:10.1044/jshd.5501.02 · Cited by 69
Speech and language therapy for dysarthria due to non-progressive brain damage
Sellars, C., Hughes, T., & Langhorne, P. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002088 · Cited by 68
Esposito, S. J., Mitsumoto, H., & Shanks, M. (2000) · Journal of Prosthetic Dentistry · doi:10.1016/s0022-3913(00)70093-x · Cited by 68 · cited 1×
“A palatal lift may temporarily improve resonance by displacing the weak soft palate to the level of normal palatal elevation and reduce hypernasality and hypophonia (19,93).”
BackgroundTemporal Acoustic Measures of Dysarthria Associated with Amyotrophic Lateral Sclerosis
Caruso, A. J., & Burton, E. K. (1987) · Journal of Speech Language and Hearing Research · doi:10.1044/jshr.3001.80 · Cited by 67 · cited 1×
“Longer stop closures and vowel duration (31), as well as reduced vowel space area, were demonstrated in ALS persons compared to healthy persons (32).”
BackgroundIntelligibility and the Acoustic Characteristics of Speech in Amyotrophic Lateral Sclerosis (ALS)
Mulligan, M., Carpenter, J., Riddel, J., Delaney, M. K., Badger, G. J., Krusinski, P. B., & Tandan, R. (1994) · Journal of Speech Language and Hearing Research · doi:10.1044/jshr.3703.496 · Cited by 67
A rapid screening battery to identify frontal dysfunction in patients with ALS
Flaherty-Craig, C., Eslinger, P., Stephens, B., & Simmons, Z. (2006) · Neurology · doi:10.1212/01.wnl.0000247667.89251.43 · Cited by 64
Deviant Speech Characteristics in Motor Neuron Disease
Carrow, E., Rivera, V. M., Mauldin, M., & Shamblin, L. (1974) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1974.00780040220014 · Cited by 62
Quantitative Voice Analysis in the Assessment of Bulbar Involvement in Amyotrophic Lateral Sclerosis
Pouget, J. (1999) · Acta Oto-Laryngologica · doi:10.1080/00016489950180702 · Cited by 61
Palatal lift prosthesis for treatment of anatomic and neurologic palatopharyngeal insufficiency.
Gonzalez, J. B., & Aronson, A. E. (1970) · PubMed · Cited by 61
Silbergleit, A. K., Johnson, A., & Jacobson, B. H. (1997) · Journal of Voice · doi:10.1016/s0892-1997(97)80081-1 · Cited by 60 · cited 3×
“Acoustic analysis may detect early involvement of the orofacial and laryngeal system (51,54), but its clinical usefulness has not been established.”
BackgroundCommunication strategies of people with ALS and their partners
Murphy, J. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820410020411 · Cited by 57 · cited 8×
“The communication strategies have to be adopted by both communication partners, patients and their listeners, which may improve the patient’s quality of life (78).”
BackgroundMethodInfluentialRapid Voice Tremor, or “Flutter,” in Amyotrophic Lateral Sclerosis
Aronson, A. E., Winholtz, W. S., Ramig, L. O., & Silber, S. R. (1992) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348949210100612 · Cited by 56
Neumann, N., Hinterberger, T., Kaiser, J., Leins, U., Birbaumer, N., & Kübler, A. (2003) · Clinical Neurophysiology · doi:10.1016/j.clinph.2003.10.030 · Cited by 50
Jankowska, E., & Tanaka, R. (1974) · Brain Research · doi:10.1016/0006-8993(74)90778-1 · Cited by 50
Language impairment in motor neurone disease
Cobble, M. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00198-1 · Cited by 46
Self-initiation of EEG-based communication in paralyzed patients
Kaiser, J., Perelmouter, J., Iversen, I. H., Neumann, N., Ghanayim, N., Hinterberger, T., Kübler, A., Kotchoubey, B., & Birbaumer, N. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(01)00470-9 · Cited by 45
Review of Respiratory Care of the Patient with Amyotrophic Lateral Sclerosis
Sherman, M. S., & Paz, H. L. (2009) · Respiration · doi:10.1159/000196308 · Cited by 45
Presentation of ALS to the otolaryngologist/head and neck surgeon: getting to the neurologist.
Hillel, A., Dray, T. G., Miller, R. P., Yorkston, K. M., Konikow, N. S., Strande, E., & Browne, J. (1999) · PubMed · Cited by 42
Otolaryngologic manifestations of amyotrophic lateral sclerosis.
Janzen, V. D., Rae, R. E., & Hudson, A. J. (1988) · PubMed · Cited by 41
Manrique, D. (2005) · Revista Brasileira de Otorrinolaringologia · doi:10.1590/s0034-72992005000500004 · Cited by 39
Meijer, J.-W. G., van Kuijk, A. A., Geurts, A. C. H., Schelhaas, H. J., & Zwarts, M. J. (2008) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e318164a931 · Cited by 38 · cited 1×
“However, acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in ALS was recently described (90).”
BackgroundDworkin, J. P. (1980) · PubMed · Cited by 37
Ono, T., Hamamura, M., Honda, K., & Nokubi, T. (2005) · Gerodontology · doi:10.1111/j.1741-2358.2005.00057.x · Cited by 36
Acoustic Differences Between Content and Function Words in Amyotrophic Lateral Sclerosis
Turner, G. S., & Tjaden, K. (2000) · Journal of Speech Language and Hearing Research · doi:10.1044/jslhr.4303.769 · Cited by 36 · cited 2×
“Speaking rate and speech intelligibility were not closely correlated in a study quantifying communication efficiency, speaking rates and intelligibility scores in normal speaking adults and dysarthric ALS patients (57).”
BackgroundQuality estimation of subdurally recorded, event-related potentials based on signal-to-noise ratio
Rohde, M. M., BeMent, S. L., Huggins, J. E., Levine, S. P., Kushwaha, R. K., & Schuh, L. A. (2002) · IEEE Transactions on Biomedical Engineering · doi:10.1109/10.972837 · Cited by 36
Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis
Manrique, D. (2005) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/s1808-8694(15)31258-1 · Cited by 36
Watts, C. R., Truong, D. D., & Nye, C. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0757-x · Cited by 34
The otolaryngologist's role in the diagnosis and treatment of amyotrophic lateral sclerosis
McGuirt, W. F., & Blalock, D. (1980) · The Laryngoscope · doi:10.1288/00005537-198009000-00011 · Cited by 34 · cited 3×
“The otolaryngologist assessment may be helpful (20).”
BackgroundSingle fiber electromyography in 78 patients with amyotrophic lateral sclerosis.
Cui, L., Liu, M., & Tang, X. (2004) · PubMed · Cited by 31
Long-Term Botulinum Toxin Dose Consistency for Treatment of Adductor Spasmodic Dysphonia
Holden, P. K., Vokes, D. E., Taylor, M. B., Till, J. A., & Crumley, R. L. (2007) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348940711601204 · Cited by 30
Spasmodic dysphonia symptoms as initial presentation of amyotrophic lateral sclerosis
Roth, C. R., Glaze, L. E., Goding, G. S., & David, W. S. (1996) · Journal of Voice · doi:10.1016/s0892-1997(96)80028-2 · Cited by 30 · cited 1×
“A strained/strangled voice (spastic dysphonia) and disruption of prosody (16) may also be present.”
BackgroundPalliative care in ALS: searching for the evidence base
Borasio, G. D. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/113-146608201300079391 · Cited by 30
Acoustic analysis of dysarthria profile in ALS patients
Tomik, B., Krupiński, J., Głodzik-Sobańska, L., Bała-Słodowska, M., Wszołek, W., Kusiak, M., & Lechwacka, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00213-0 · Cited by 27 · cited 1×
“Acoustic analysis may detect early involvement of the orofacial and laryngeal system (51,54), but its clinical usefulness has not been established.”
BackgroundSelf-citationMcGuirt, W. F., & Strout, J. J. (1980) · The Laryngoscope · doi:10.1288/00005537-198012000-00016 · Cited by 25
Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia
Casserly, P., & Timon, C. I. (2007) · The Journal of Laryngology & Otology · doi:10.1017/s0022215107007852 · Cited by 23
Nasal speaking valve: a device for managing velopharyngeal incompetence1
Suwaki, M., NANBA, K., ITO, E., Kumakura, I., & Minagi, S. (2008) · Journal of Oral Rehabilitation · doi:10.1111/j.1365-2842.2007.01800.x · Cited by 19
Profile of laryngological abnormalities in patients with amyotrophic lateral sclerosis
Tomik, J., Tomik, B., Partyka, D., Składzień, J., & Szczudlik, A. (2007) · The Journal of Laryngology & Otology · doi:10.1017/s002221510700610x · Cited by 19 · cited 1×
“Norris, scale Norris, 1974 (36) Appel scale Appel, 1987 (35) ALS Severity Scale-Speech Hillel, 1989 (33) Charing Cross scales Guiloff, 1990 (39) Goonetilleke, 1994 (37) Guiloff, 1994 (40) Goonetilleke, 1995 (38) Guiloff, 1995 (41) ALSFRS -R Cedarbaum, 1999 (34) Frenchay Dysarthria scale Enderby, 1980 (58) Otolaryngolo…”
Self-citationGuiloff, R. J., & Goonetilleke, A. (1995) · PubMed · Cited by 18
Self-citationAmyotrophic Lateral Sclerosis: The Search for a Spectroscopic Marker of Upper Motoneuron Involvement
Bowen, B. C., & Bradley, W. G. (2001) · Archives of Neurology · doi:10.1001/archneur.58.5.714 · Cited by 18
Riddel, J., McCauley, R. J., Mulligan, M., & Tandan, R. (1995) · Journal of Speech Language and Hearing Research · doi:10.1044/jshr.3802.304 · Cited by 18 · cited 1×
“Early phonetic disturbances of speech were detected in dysarthric as well as in non-dysarthric highly intelligible ALS subjects and were most marked in the dysarthric cases (45).”
BackgroundThe Management of Motor Neuron Disease
Hewer, R. L. (1995) · Springer eBooks · doi:10.1007/978-1-4471-1871-8_16 · Cited by 16
Corneomandibular reflex in ALS
Okuda, B., Kodama, N., Kawabata, K., Tachibana, H., & Sugita, M. (1999) · Neurology · doi:10.1212/wnl.52.8.1699 · Cited by 14
Klasner, E. R., Yorkston, K. M., & Strand, E. A. (1999) · Journal of medical speech-language pathology · Cited by 13
Palliative care in ALS: searching for the evidence base
Borasio, G. D. (2001) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820152415717 · Cited by 12
The use of intra-oral appliances in the management of acquired velopharyngeal disorders
Enderby, P., Hathorn, I. S., & Servant, S. (1984) · BDJ · doi:10.1038/sj.bdj.4805453 · Cited by 11
Goonetilleke, A., & Guiloff, R. J. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.2.201 · Cited by 9 · cited 2×
“Norris, scale Norris, 1974 (36) Appel scale Appel, 1987 (35) ALS Severity Scale-Speech Hillel, 1989 (33) Charing Cross scales Guiloff, 1990 (39) Goonetilleke, 1994 (37) Guiloff, 1994 (40) Goonetilleke, 1995 (38) Guiloff, 1995 (41) ALSFRS -R Cedarbaum, 1999 (34) Frenchay Dysarthria scale Enderby, 1980 (58) Otolaryngolo…”
Self-citationElectromiograma de fibra única en 18 pacientes con esclerosis lateral amiotrófica
Avarvarei, L. D., Ochoa, J. H. P., Garrido, J. M. C., Ballesteros, R. J.-C., & Monasterio, J. U. (2005) · Revista de Neurología · doi:10.33588/rn.4003.2004340 · Cited by 7
The Effect of Botulinum Toxin A on the Vocal Symptoms of Spastic Dysarthria
McHenry, M. A., Whatman, J., & Pou, A. M. (2002) · Journal of Voice · doi:10.1016/s0892-1997(02)00081-4 · Cited by 7 · cited 1×
“Botulinum toxin type A has been reported as effective in spastic dysarthria (80) and spasmodic dysphonia (81 84).”
BackgroundGoonetilleke, A., & Guiloff, R. J. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90181-3 · Cited by 6
Self-citationTomik, B., Głodzik-Sobańska, L., Lechwacka, A., Bała-Słodowska, M., Kolasa, M., & Szczudlik, A. (2000) · PubMed · Cited by 2
Self-citation
Research works printed but not linked: 14
- Yorkston KM, Strand E, Miller R, Hillel A, Smith K. Speech deterioration in amyotrophic lateral sclerosis: implications for the timing of intervention. J Med Speech Lang Pathol. 1993; 1: 35–46
- Mitsumoto H, Chad DA, Pioro EK. Speech and communication management. Amyotrophic Lateral Sclerosis, H Mitsumoto, DA Chad, EK Pioro. FA Davis Co, New York 1998; 405–20
- 10.1044/jshr.3805.1001 · DOI · Paper page
- Guiloff, RJ, Modarres-Sadeghi, H, Rogers, H. Motor neuron disease: aims and assessment methods in trial design, In:. F Clifford-Rose. Methodological Problems in Clinical Neurologic Trials. Vol. 1. Amyotrophic Lateral Sclerosis. New York, Demos. 1990; 19–31
- Guiloff RJ, Goonetilleke A. Longitudinal clinical assessments in motor neuron disease. Relevance to clinical trials. ALS – From Charcot to the Present and into the Future, F Clifford-Rose. Smith-Gordon/Nishimura, London 1994; 73–82
- SJ Robertson. Robertson Dysarthria Profile. Bicester Winslow Press. 1982
- Gray's Anatomy38th edn. London, Churchill Livingstone. 1995; 1230–58
- Carpenter RJ, McDonald TJ, Howard FM. The otolaryngological presentation of amyotrophic lateral sclerosis. J Otol Rhinol Laryngol. 1978; 86: 479–84
- Dworkin JP. Tongue strength measurement in patients with amyotrophic lateral sclerosis: qualitative versus quantitative procedures. Arch Phys Med Rehab. 1980; 61: 422–4
- Yorkston KM. Management of dysarthria in amyotrophic lateral sclerosis. Geriatr Aging. 2002; 5: 38–41
- Gelinas D, Miller RG. A treatable disease: a guide to the management of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, RHJr Brown, V Meininger, M Swash. Martin Dunitz, London 2000; 405–21
- 10.1037/0033-2909.127.3.358 · doi:10.1037/0033-2909.127.3.358 · Paper page
- 10.1016/s0028-3932(99)00146-3 · DOI · Paper page
- 10.1016/s0093-934x(03)00357-2 · DOI · Paper page
Cited by
Silent Speech Interfaces for Speech Restoration: A Review
González, J. A., Gomez-Alanis, A., Martín-Doñas, J. M., Pérez-Córdoba, J. L., & Gomez, A. M. (2020) · IEEE Access · doi:10.1109/access.2020.3026579 · Cited by 187
“with other neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS), affecting more than 80% of these patients [67].”
Background(2003) · Fragments of Neurological History · doi:10.1142/9781860949364_0015 · Cited by 187
Tăuţan, A.-M., Ionescu, B. E., & Santarnecchi, E. (2021) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2021.102081 · Cited by 174
Clinical Measures of Bulbar Dysfunction in ALS
Yunusova, Y., Plowman, E. K., Green, J. R., Barnett, C., & Bede, P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00106 · Cited by 169
Caligari, M., Godi, M., Guglielmetti, S., Franchignoni, F., & Nardone, A. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.803576 · Cited by 161
Metadata
- Authors
- Tomik, B., & Guiloff, R. J.
- Affiliations
- Jagiellonian University (PL)
- Charing Cross Hospital (GB)
- Corresponding author
- Tomik, Barbara
- ORCID
- Guiloff, Roberto J.
- Venue
- Amyotrophic Lateral Sclerosis
- Publisher
- Informa UK Limited
- Published
- 2010-01
- Volume
- 11
- Issue
- 1-2
- Pages
- 4-15
- ISSN
- 1471-180X (ISSN-L)
- 1748-2968
- OpenAlex
- W2022683396
- Cited by
- 201
- References
- 106
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 20 · 2023: 23 · 2022: 13 · 2021: 14 · 2020: 17 · 2019: 14 · 2018: 15 · 2017: 7 · 2016: 13 · 2015: 11 · 2014: 6 · 2013: 7 · 2012: 3
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Amyotrophic Lateral Sclerosis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Health Professions › Occupational Therapy › Assistive Technology in Communication and Mobility
- Keywords
- dysarthria, speech disorders, articulation, intelligibility, phonation, communication loss, differential diagnosis, pathophysiology, dysarthria assessment, speech therapy
- MeSH terms
- Amyotrophic Lateral Sclerosis, Dysarthria, Humans, Speech Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.